MedApps to test remote monitoring of CHF patients

In an emerging industry like mobile healthcare, the more data demonstrating the efficacy of technology, the better. MedApps, maker of remote patient monitoring devices, will be collecting such data on patients with congestive heart failure in an attempt to show that daily monitoring of discharged patients can reduce readmission rates and ER utilization.

Scottsdale, Ariz.-based MedApps will test its HealthPAL wireless EMR connectivity tool and web-based HealthCOM portal on CHF patients discharged from Meridian Health hospitals in New Jersey as part of a disease management pilot. The systems will monitor patient vital signs and symptoms immediately after discharge and, the company says, provide patient-specific education and support. The devices also should be able to help Meridian care managers identify complications and symptoms so patients can get the necessary outpatient care before the problem develops into something requiring hospital admission.

To learn more about this test and the technology:
- read this MedApps press release

Suggested Articles

The newly launched Center for Connected Health will be largest telehealth hub in the Philadelphia region, according to Penn Medicine.

The FDA commissioner wants to use additional funding under Trump's budget to advance digital health initiatives and integrate real-world data.

The FDA's approval of an app that uses AI to notify specialists of a potential stroke offers new possibilities for triage software that uses CDS.